Document is current
Any future updates will be listed below
-
Authors
Katsumata, Yuriko
Wu, Xian
Aung, Khine Zin
Fardo, David W.
Woodworth, Davis C.
Sajjadi, S. Ahmad
Tomé, Sandra O.
Thal, Dietmar Rudolf
Troncoso, Juan C.
Chang, Koping
Mock, Charles
Nelson, Peter T.
- License Information
-
More Information
Article History
Received: 27 August 2024
Revised: 25 October 2024
Accepted: 30 October 2024
First Online: 15 November 2024
Declarations
:
: DRT & SOT received consultant honorary from Muna Therapeutics (Belgium). DRT collaborated with Novartis Pharma AG (Switzerland), and GE-Healthcare (UK). DRT and PTN are members of <i>Acta </i><i>Neuropathologica </i>editorial board. They were not involved in the assessment or decision-making process for this manuscript. The other authors declare that they have no competing interests.
: For all NACC data, only anonymized summary information was used. Institutional review board approval and informed consent were obtained from all participants at each of individual AD Research Center (ADRC). Under those auspices, informed consent was obtained from all individual participants included in the study. See
: Not applicable.
